Virtual care company Synapticure has secured $25 million in Series A funding to expand its platform providing care for patients with neurodegenerative diseases, a health issue that disproportionately impacts women both as patients and caregivers. The round was led by B Capital, with participation from CommonSpirit Health, CVS Health Ventures, Google Ventures, Optum Ventures, Rock Health Capital, RA Capital Management, and Nexus…
AbbVie has announced the acquisition of Aliada Therapeutics for $1.4 billion in cash, strengthening its position in neuroscience drug development. The deal centers on Aliada’s novel blood-brain barrier (BBB)-crossing technology and its lead Alzheimer’s disease candidate, ALIA-1758, a development particularly significant given that women represent nearly two-thirds of Americans living with Alzheimer’s disease. Aliada’s proprietary MODEL platform enables high-precision central nervous system…
The Women’s Brain Foundation (WBF) and Medscape Education have joined forces to address a critical gap in medical education. the two organizations announced the launch of a new learning center focused on sex and gender differences in brain and mental health care. The WBF, established in 2017, has been at the forefront of promoting the inclusion of sex and gender-based evidence in…
ShiraTronics, a medical device company developing neurostimulation therapy for chronic migraine patients, has successfully closed a $66 million Series B financing round. The funding round was led by Norwest Venture Partners, with participation from new investors Seroba, OSF Ventures, the Global BioAccess Fund, and an undisclosed strategic investor. Returning investors U.S. Venture Partners, Amzak Health, Treo Ventures, and Aperture Venture Partners also…
Eli Lilly’s Kisunla (donanemab-azbt) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of early symptomatic Alzheimer’s disease. This includes adults with mild cognitive impairment (MCI) and mild dementia stages of the disease. Alzheimer’s disease affects women disproportionately, with nearly two-thirds of Americans diagnosed being women. The pivotal Phase 3 study, TRAILBLAZER-ALZ 2, showed that Kisunla slowed…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
Autoimmune disease happens when the body’s natural defense system can’t tell the difference between own cells and foreign cells, causing the body to attack normal cells mistakenly. One of the most common autoimmune diseases is multiple sclerosis (in short MS), a potentially disabling disease of the central nervous system. In MS, the immune system attacks the protective sheath that covers nerve fibers and causes communication…
Dementia describes a set of symptoms that over time can affect memory, problem-solving, language and behaviour. Alzheimer’s disease is the most common type of dementia. On a global level women with dementia outnumber men 2 to 1. Brain scans have shown that brain cells are dying faster in the women’s than men’s brains. Researchers at the universities of Bath and Bristol, in…
